(Q37853060)

24 August 2017

1 reference

title

The many faces of the contact pathway and their role in thrombosis (English)

1 reference

24 August 2017

0 references

Rebecca S Woodruff

1

1 reference

24 August 2017

Bruce Sullenger

series ordinal

2

1 reference

24 August 2017

Richard C Becker

series ordinal

3

1 reference

24 August 2017

publication date

1 July 2011

1 reference

Journal of Thrombosis and Thrombolysis

24 August 2017

published in

1 reference

24 August 2017

volume

32

1 reference

24 August 2017

issue

1

1 reference

24 August 2017

page(s)

9-20

1 reference

WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING.

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XI activation in a revised model of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Step-by-step evolution of vertebrate blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Evolution of the contact phase of vertebrate blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Orphan receptor hepatocyte nuclear factor-4 antagonizes estrogen receptor alpha-mediated induction of human coagulation factor XII gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

A familial hemorrhagic trait associated with a deficiency of a clot-promoting fraction of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Amino acid sequence of human factor XI, a blood coagulation factor with four tandem repeats that are highly homologous with plasma prekallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

The molecular basis of blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Real-time quantitative PCR analysis of factor XI mRNA variants in human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XII: what does it contribute to our understanding of the physiology and pathophysiology of hemostasis & thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

The relationship of structure and function in human Hageman factor. The association of enzymatic and binding activities with separate regions of the molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Role of surface in surface-dependent activation of Hageman factor (blood coagulation Factor XII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Kinetics of activation and autoactivation of human factor XII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Dual role of collagen in factor XII-dependent thrombus formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Polyphosphate modulates blood coagulation and fibrinolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Extracellular RNA constitutes a natural procoagulant cofactor in blood coagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Activation of the classical pathway of complement by Hageman factor fragment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Role of the contact system in fibrinolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

The role of high molecular weight kininogen and prothrombin as cofactors in the binding of factor XI A3 domain to the platelet surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Location of the disulfide bonds in human coagulation factor XI: the presence of tandem apple domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Crystal structure of the factor XI zymogen reveals a pathway for transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Characterization of Novel Forms of Coagulation Factor XIa: independence of factor XIa subunits in factor IX activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Model for a factor IX activation complex on blood platelets: dimeric conformation of factor XIa is essential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Laminin promotes coagulation and thrombus formation in a factor XII-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Effects of factor IX or factor XI deficiency on ferric chloride-induced carotid artery occlusion in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Defective thrombus formation in mice lacking coagulation factor XII

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Targeting coagulation factor XII provides protection from pathological thrombosis in cerebral ischemia without interfering with hemostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Enhanced cortical reperfusion protects coagulation factor XII-deficient mice from ischemic stroke as revealed by high-field MRI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an anti-fibrinolytic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XI contributes to thrombus propagation on injured neointima of the rabbit iliac artery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Prevention of vascular graft occlusion and thrombus-associated thrombin generation by inhibition of factor XI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Inhibition of factor XI reduces thrombus formation in rabbit jugular vein under endothelial denudation and/or blood stasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Deletion of murine kininogen gene 1 (mKng1) causes loss of plasma kininogen and delays thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Bradykinin B2 receptor knockout mice are protected from thrombosis by increased nitric oxide and prostacyclin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Release of bradykinin and expression of kinin B2 receptors in the brain: role for cell death and brain edema formation after focal cerebral ischemia in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

The occasional venous thromboses seen in patients with severe (homozygous) FXII deficiency are probably due to associated risk factors: a study of prevalence in 21 patients and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Homozygosity for the C-->T polymorphism at nucleotide 46 in the 5' untranslated region of the factor XII gene protects from development of acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Myocardial infarction and arterial thrombosis in severe (homozygous) FXII deficiency: no apparent causative relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

John Hageman's factor and deep-vein thrombosis: Leiden thrombophilia Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Evidence of a U-shaped association between factor XII activity and overall survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Inherited factor XI deficiency confers no protection against acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XI contributes to thrombin generation in the absence of factor XII

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Inactivation of plasminogen activator inhibitor type 1 by activated factor XII plays a role in the enhancement of fibrinolysis by contact factors in-vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Platelets promote coagulation factor XII-mediated proteolytic cascade systems in plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Binding of coagulation factor XI to washed human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

A catalytic domain exosite (Cys527-Cys542) in factor XIa mediates binding to a site on activated platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Blood coagulation factor XIa binds specifically to a site on activated human platelets distinct from that for factor XI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Identification of coagulation factor XI as a ligand for platelet apolipoprotein E receptor 2 (ApoER2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Structural and mutational analyses of the molecular interactions between the catalytic domain of factor XIa and the Kunitz protease inhibitor domain of protease nexin 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Activation of blood clotting factors by microbial proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Activation of the contact-phase system on bacterial surfaces--a clue to serious complications in infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Polyphosphate exerts differential effects on blood clotting, depending on polymer size.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Cross-talk of the renin-angiotensin and kallikrein-kinin systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

The plasma kallikrein-kinin system counterbalances the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Chemerin activation by serine proteases of the coagulation, fibrinolytic, and inflammatory cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Induction of expression of monocyte interleukin 1 by Hageman factor (factor XII)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Isolation and characterization of the kininogen-binding protein p33 from endothelial cells. Identity with the gC1q receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Identification of the zinc-dependent endothelial cell binding protein for high molecular weight kininogen and factor XII: identity with the receptor that binds to the globular "heads" of C1q (gC1q-R)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Assembly, activation, and signaling by kinin-forming proteins on human vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XII stimulates ERK1/2 and Akt through uPAR, integrins, and the EGFR to initiate angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Inhibition of factor XIa as a new approach to anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

COU254, a specific 3-carboxamide-coumarin inhibitor of coagulation factor XII, does not protect mice from acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Infestin, a thrombin inhibitor presents in Triatoma infestans midgut, a Chagas' disease vector: gene cloning, expression and characterization of the inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Early atherosclerosis exhibits an enhanced procoagulant state.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Factor XIIa inhibitor recombinant human albumin Infestin-4 abolishes occlusive arterial thrombus formation without affecting bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Design, synthesis, and biological evaluation of peptidomimetic inhibitors of factor XIa as novel anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Identification of a Binding Site for Glycoprotein Ibα in the Apple 3 Domain of Factor XI

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Kallikrein-Kinin System in Neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

C1 inhibitor, a multi-functional serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11239-011-0578-5

Platelet polyphosphate: an endogenous activator of coagulation factor XII

21 January 2018

1 reference

12 December 2020

Functional characterization of platelet-bound factor XIa: retention of factor XIa activity on the platelet surface

1 reference

12 December 2020

Characterization of human blood coagulation factor XII cDNA. Prediction of the primary structure of factor XII and the tertiary structure of beta-factor XIIa

1 reference

12 December 2020

Fibrinolytic properties of activated FXII

1 reference

12 December 2020

Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation

1 reference

12 December 2020

Probing single-stranded DNA and its biomolecular interactions through direct catalytic activation of factor XII, a protease of the blood coagulation cascade

1 reference

12 December 2020

Definition of the bleeding tendency in factor XI-deficient kindreds--a clinical and laboratory study.

1 reference

12 December 2020

Role of hepatocyte nuclear factor 4alpha in control of blood coagulation factor gene expression

1 reference

12 December 2020

Human blood coagulation factor XI. Purification, properties, and mechanism of activation by activated factor XII

1 reference

12 December 2020

Inhibition of activated Hageman factor and activated plasma thromboplastin antecedent by purified serum C1 inactivator

1 reference

12 December 2020

Activation of human blood coagulation factor XI independent of factor XII. Factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces

1 reference

12 December 2020

The contact system: a proinflammatory pathway with antithrombotic activity

1 reference

12 December 2020

Surface-independent acceleration of factor XII activation by zinc ions. I. Kinetic characterization of the metal ion rate enhancement.

1 reference

12 December 2020

Selective stimulation of tissue-type plasminogen activator (t-PA) in vivo by infusion of bradykinin

1 reference

12 December 2020

Plasma levels of bradykinin are suppressed in factor XII-deficient mice.

1 reference

12 December 2020

Contributions of human platelets to the proteolytic activation of blood coagulation factors XII and XI.

1 reference

12 December 2020

The cleavage and formation of activated human Hageman factor by autodigestion and by kallikrein

1 reference

12 December 2020

Factor XII-dependent contact activation on endothelial cells and binding proteins gC1qR and cytokeratin 1

1 reference

12 December 2020

Factor XII does not initiate prekallikrein activation on endothelial cells

1 reference

12 December 2020

Factor XI-dependence of surface- and tissue factor-initiated thrombus propagation in primates

1 reference

12 December 2020

Reduced incidence of ischemic stroke in patients with severe factor XI deficiency

1 reference

12 December 2020

Autoactivatability of human Hageman factor (factor XII)

1 reference

12 December 2020

Identification of a factor IX binding site on the third apple domain of activated factor XI

1 reference

12 December 2020

Elevated factor XI activity levels are associated with an increased odds ratio for cerebrovascular events

1 reference

12 December 2020

Novel 3-carboxamide-coumarins as potent and selective FXIIa inhibitors

1 reference

12 December 2020

High levels of coagulation factor XI as a risk factor for venous thrombosis

1 reference

12 December 2020

Assembly of contact-phase factors on the surface of the human neutrophil membrane

1 reference

12 December 2020

Structural analysis of eight novel and 112 previously reported missense mutations in the interactive FXI mutation database reveals new insight on FXI deficiency.

1 reference

12 December 2020

Effects of factor XI deficiency on ferric chloride-induced vena cava thrombosis in mice

1 reference

12 December 2020

Feedback activation of factor XI by thrombin in plasma results in additional formation of thrombin that protects fibrin clots from fibrinolysis

1 reference

12 December 2020

Antithrombotic and hemostatic effects of a small molecule factor XIa inhibitor in rats

1 reference

12 December 2020

Effect of bradykinin and thrombin on prostacyclin synthesis in endothelial cells from calf and pig aorta and human umbilical cord vein

1 reference

12 December 2020

FXI is essential for thrombus formation following FeCl3-induced injury of the carotid artery in the mouse

1 reference

12 December 2020

Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk

1 reference

12 December 2020

Factor XI dependent and independent activation of thrombin activatable fibrinolysis inhibitor (TAFI) in plasma associated with clot formation

1 reference

12 December 2020

Extrinsic pathway proteolytic activity

1 reference

12 December 2020

Molecular characterization of FXI deficiency

1 reference

12 December 2020

Purified plasma factor XIIa aggregates human neutrophils and causes degranulation

1 reference

12 December 2020

The prevalence of factor XII deficiency in 103 orally anticoagulated outpatients suffering from recurrent venous and/or arterial thromboembolism

1 reference

12 December 2020

Blood coagulation in hemophilia A and hemophilia C.

1 reference

12 December 2020

Human factor XII (Hageman factor) autoactivation by dextran sulfate. Circular dichroism, fluorescence, and ultraviolet difference spectroscopic studies

1 reference

12 December 2020

Hageman factor (factor XII) deficiency in marine mammals

1 reference

12 December 2020

Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation

1 reference

12 December 2020

Synthesis of peptides of arginine chloromethyl ketone. Selective inactivation of human plasma kallikrein

1 reference

12 December 2020

Anaphylatoxins: C3a and C5a

1 reference

12 December 2020

Molecular genetics of C1 inhibitor

1 reference

12 December 2020

Defective binding of factor XI-N248 to activated human platelets

1 reference

12 December 2020

Activation of blood clotting factors by microbial proteinases

1 reference

12 December 2020

Activation of the plasma kallikrein/kinin system on cells: a revised hypothesis.

1 reference

12 December 2020

Murine prolylcarboxypeptidase depletion induces vascular dysfunction with hypertension and faster arterial thrombosis

1 reference

12 December 2020

Interaction of high molecular weight kininogen binding proteins on endothelial cells

1 reference

12 December 2020

Pathogenesis of serratial infection: activation of the Hageman factor-prekallikrein cascade by serratial protease

1 reference

12 December 2020

Thrombin activates factor XI on activated platelets in the absence of factor XII

1 reference

12 December 2020

Amino acid sequence of the heavy chain of human alpha-factor XIIa (activated Hageman factor)

1 reference

12 December 2020

Distinctive regulation of contact activation by antithrombin and C1-inhibitor on activated platelets and material surfaces

1 reference

12 December 2020

Molecular cloning and sequence analysis of the cDNA for a human serine protease reponsible for activation of hepatocyte growth factor. Structural similarity of the protease precursor to blood coagulation factor XII

1 reference

12 December 2020

Human factor XII binding to the glycoprotein Ib-IX-V complex inhibits thrombin-induced platelet aggregation

1 reference

12 December 2020

Activation of bovine factor VII by hageman factor fragments

1 reference

12 December 2020

Fifty years of research on the plasma kallikrein-kinin system: from protein structure and function to cell biology and in-vivo pathophysiology.

1 reference

12 December 2020

Inhibition of the intrinsic coagulation pathway factor XI by antisense oligonucleotides: a novel antithrombotic strategy with lowered bleeding risk.

1 reference

12 December 2020

10.1007/S11239-011-0578-5

Identifiers

DOI

1 reference

24 August 2017

1 reference